National Institutes of Health-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

    eLife, Vol. 9